
 
 
 
 
 
 
 
 
   
   1 . A p 1 90 protein that has an amino acid sequence comprising at least 75% identity with the amino acid sequence of SEQ ID NO: 2;
 wherein said protein is in a form selected from the group consisting of isolated, recombinant, or both isolated and recombinant.   
 
     
   2 . The protein of  claim 1  wherein the amino acid sequence is selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 2 comprising one or more conservative amino acid substitutions. 
 
     
   3 . An antigenic fragment of the p 1 90 protein that has the amino acid sequence of SEQ ID NO: 2. 
 
     
   4 . A chimeric polypeptide that comprises the antigenic fragment of  claim 3 . 
 
     
   5 . An antibody elicited by the p 1 90 protein of  claim 1 , or elicited by an antigenic fragment of said protein. 
 
     
   6 . A nucleic acid that encodes the p 1 90 protein of  claim 1 ; wherein said nucleic acid is in a form selected from the group consisting of isolated, recombinant, or both isolated and recombinant. 
 
     
   7 . The nucleic acid of  claim 6  that comprises a nucleotide sequence selected from the group consisting of the nucleotide sequence of SEQ ID NO: 1, a nucleotide sequence of a DNA molecule that hybridizes under stringent conditions with the nucleic acid having the nucleotide sequence of SEQ ID NO: 1, and the nucleotide sequence of SEQ ID NO: 5. 
 
     
   8 . An expression vector comprising the nucleic acid of  claim 7 . 
 
     
   9 . The expression vector of  claim 8  that is the EGT1 plasmid having the BCCM accession No. LMBP 5690. 
 
     
   10 . A host cell that comprises the expression vector of  claim 8 . 
 
     
   11 . A method for producing a recombinant p 1 90 protein comprising culturing the host cell of  claim 10  in a culture medium. 
 
     
   12 . The method of  claim 11  that further comprises isolating the p 1 90 protein. 
 
     
   13 . The method of  claim 12  wherein the host cell is an  E. coli  cell. 
 
     
   14 . A p 2 90 protein that has an amino acid sequence comprising at least 75% identity with the amino acid sequence of SEQ ID NO: 4;
 is wherein said protein is in a form selected from the group consisting of isolated, recombinant, or both isolated and recombinant.   
 
     
   15 . The protein of  claim 14  wherein the amino acid sequence is selected from the group consisting of SEQ ID NO: 4 and SEQ ID NO: 4 comprising one or more conservative amino acid substitutions. 
 
     
   16 . An antigenic fragment of the p 2 90 protein that has the amino acid sequence of SEQ ID NO: 4. 
 
     
   17 . A chimeric polypeptide that comprises the antigenic fragment of  claim 16 . 
 
     
   18 . An antibody elicited by the p 2 90 protein of  claim 14 , or elicited by an antigenic fragment of said protein. 
 
     
   19 . A nucleic acid that encodes the p 2 90 protein of  claim 14 ; wherein said nucleic acid is in a form selected from the group consisting of isolated, recombinant, or both isolated and recombinant. 
 
     
   20 . The nucleic acid of  claim 19  that comprises a nucleotide sequence selected from the group consisting of the nucleotide sequence of SEQ ID NO: 3, a nucleotide sequence of a DNA molecule that hybridizes under stringent conditions with the nucleic acid having the nucleotide sequence of SEQ ID NO: 3, and the nucleotide sequence of SEQ ID NO: 6. 
 
     
   21 . An expression vector comprising the nucleic acid of  claim 20 . 
 
     
   22 . The expression vector of  claim 21  that is the EGT1 plasmid having the BCCM accession No. LMBP 5691. 
 
     
   23 . A host cell that comprises the expression vector of  claim 21 . 
 
     
   24 . A method for producing a recombinant p 2 90 protein comprising culturing the host cell of  claim 23  in a culture medium. 
 
     
   25 . The method of  claim 24  that further comprises isolating the p 2 90 protein. 
 
     
   26 . The method of  claim 25  wherein the host cell is an  E. coli  cell. 
 
     
   27 . A vaccine that comprises an antigenically effective amount of a protein selected from the group consisting of a p 1 90 protein that has an amino acid sequence comprising at least 70% identity with the amino acid sequence of SEQ ID NO: 2, a p 2 90 protein that has an amino acid sequence comprising at least 70% identity with the amino acid sequence of SEQ ID NO: 4, and a mixture of said p 1 90 protein and said p 2 90 protein. 
 
     
   28 . The vaccine of  claim 27  that further comprises a 45 protein or antigenic fragment thereof. 
 
     
   29 . The vaccine of  claim 27  that further comprises a bacterin comprised of a  Yersinia ruckeri  cell selected from the group consisting of BCCM accession No. of LMG P-22044, BCCM accession No. LMG P-22511, and combinations thereof. 
 
     
   30 . The vaccine of any of  claims 27  that further comprising an antigen obtained from an Infectious Pancreatic Necrosis (IPN) virus. 
 
     
   31 . The vaccine of  claim 30  wherein the antigen obtained from the IPN virus is selected from the group consisting of the VP2 var protein and the VP3 protein. 
 
     
   32 . The vaccine of  claim 27  further comprising both the VP2 var protein and the VP3 protein from Infectious Pancreatic Necrosis (IPN) virus. 
 
     
   33 . The vaccine of  claim 32  wherein the VP2 var protein is obtained from a is transformed  Pichia pastoris  cell, BCCM Accession No. IHEM 20069 and the VP3 protein is obtained from a transformed  Pichia pastoris  cell, BCCM Accession No. IHEM 20071. 
 
     
   34 . The vaccine of  claim 33  wherein the VP2 var protein is obtained from a transformed  Pichia pastoris  cell, BCCM Accession No. IHEM 20070 and the VP3 protein is obtained from a transformed  Pichia pastoris  cell, BCCM Accession No. IHEM 20072. 
 
     
   35 . The vaccine  claim 27  that further comprises an antigen obtained from  Aeromonas salmonicida.    
 
     
   36 . A method of protecting a fish from salmonid rickettsial septicemia comprising administering to the fish the vaccine of  claim 27 . 
 
     
   37 . The method of  claim 36  wherein the fish is a teleost. 
 
     
   38 . The method of  claim 37  wherein the teleost is a salmonid. 
 
     
   39 . A method of protecting a fish from salmonid rickettsial septicemia and Infectious Pancreatic Necrosis comprising administering the vaccine of  claim 33  to the fish. 
 
     
   40 . The method of  claim 36  wherein the fish is a salmonid. 
 
     
   41 . The method of  claim 40  wherein the salmonid is selected from the group consisting of a  Salmo salar , an  Oncorhynchus kisutch  and an  Oncorhynchus mykiss.    
 
   
 
 
 
 
 
 
 
 
